Placement and Entitlement Offer to raise up to $8.37 million
Filed with ASX · · 5 pages · English
In the deck
Earlier from Adherium
- First Patient Enrolled in Major e-health Clinical Study
- Adherium receives $1.5m Australian R&D Tax Rebate
- New CEO Appointed - Dr Paul Mastoridis
- Resignation of CEO
- Notice of Annual General Meeting/Proxy Form
Later from Adherium
- Non-Renounceable Rights Issue Offer Completes
- AstraZeneca selected Adherium Smartinhaler for its study
- Management Change
- Adherium Secures $2.6M to Advance Smart Inhaler in US
- $900K Capital Raise to Accelerate Smart Inhaler in US
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium